You are here: Home » News-CM » Companies » News
Business Standard

Alembic Pharmaceuticals' JV Aleor Dermaceuticals undergoes USFDA inspection at its Karakhadi facility

Capital Market 

with one observation

Alembic Pharmaceuticals announced that Aleor Dermaceuticals (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals (Alembic) and Orbicular Pharmaceutical Technologies (Orbicular), has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; with one observation. The inspection was carried out from 16 September, 2019 to 20 September, 2019.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, September 23 2019. 15:32 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU